Akebia Therapeutics Ownership | Who Owns Akebia Therapeutics?
Akebia Therapeutics Ownership Summary
Akebia Therapeutics is owned by 27.44% institutional investors, 2.09% insiders, and 70.47% retail investors. Blackrock is the largest institutional shareholder, holding 5.68% of AKBA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.83% of its assets in Akebia Therapeutics shares.
AKBA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Akebia Therapeutics | 27.44% | 2.09% | 70.47% |
| Sector | Healthcare Stocks | 46.98% | 7.90% | 45.12% |
| Industry | Biotech Stocks | 44.85% | 7.67% | 47.48% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 11.64M | 5.68% | $11.87M |
| Vanguard group | 9.28M | 4.53% | $9.46M |
| Alerce investment management | 5.75M | 2.80% | $5.86M |
| Geode capital management | 4.54M | 2.21% | $4.63M |
| Acadian asset management | 4.06M | 1.98% | $4.14M |
| Renaissance | 3.91M | 1.91% | $3.99M |
| State street | 2.75M | 1.34% | $2.80M |
| Jacobs levy equity management | 2.09M | 1.02% | $2.14M |
| Qube research | 1.74M | 0.85% | $1.78M |
| Connor, clark & lunn investment management | 1.05M | 0.51% | $1.07M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alerce investment management | 5.75M | 11.49% | $5.86M |
| Orchard capital management | 86.83K | 0.03% | $88.56K |
| Acadian asset management | 4.06M | 0.01% | $4.14M |
| Wealth effects | 27.00K | 0.01% | $27.54K |
| Eagle wealth strategies | 12.00K | 0.01% | $12.24K |
| Jacobs levy equity management | 2.09M | 0.01% | $2.14M |
| State of wyoming | 49.73K | 0.01% | $50.72K |
| Cedrus | 13.70K | 0.01% | $13.97K |
| Renaissance | 3.91M | 0.01% | $3.99M |
| Compass ion advisors | 25.09K | 0.01% | $45.92K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 11.64M | 0.00% | 9.10M |
| Geode capital management | 4.54M | 0.00% | 2.72M |
| State street | 2.75M | 0.00% | 2.10M |
| Vanguard group | 9.28M | 0.00% | 1.05M |
| Bank of new york mellon | 604.55K | 0.00% | 585.79K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alerce investment management | 5.75M | 11.49% | -7.46M |
| Millennium management | 45.69K | - | -3.22M |
| Acadian asset management | 4.06M | 0.01% | -1.25M |
| Goldman sachs group | 348.92K | 0.00% | -1.06M |
| Marshall wace, llp | 247.07K | 0.00% | -776.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nuveen asset management | 380.54K | 0.00% | 380.54K | $388.15K |
| Corebridge financial | 111.91K | 0.00% | 111.91K | $115.27K |
| New york state common retirement fund | 101.10K | 0.00% | 101.10K | $103.00K |
| Alliancebernstein | 77.64K | - | 77.64K | $79.19K |
| Voya investment management | 71.70K | 0.00% | 71.70K | $73.13K |
Sold Out
| Holder | Change |
|---|---|
| Hexagon capital partners | -186.00 |
| Capital advisors | -320.00 |
| Nbc securities | -690.00 |
| Truvestments capital | -756.00 |
| Guggenheim capital | -1.04K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 108 | -14.29% | 56,234,084 | -1.41% | 27 | 3.04% | 53 | -27.40% | 24 | - |
| Mar 31, 2024 | 126 | 38.46% | 57,038,634 | 4.20% | 30 | 3.55% | 73 | 97.30% | 24 | 14.29% |
| Dec 31, 2023 | 91 | 13.75% | 54,737,421 | 7.65% | 29 | 3.92% | 37 | 32.14% | 21 | - |
| Sep 30, 2023 | 80 | -3.61% | 50,849,494 | 1.12% | 27 | 3.67% | 28 | -6.67% | 21 | -4.55% |
| Jun 30, 2023 | 83 | 18.57% | 50,284,843 | -3.26% | 27 | 3.44% | 30 | 7.14% | 22 | 57.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.95M | 2.83% | - |
| iShares Russell 2000 ETF | 5.53M | 2.63% | -12.43K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.60M | 1.24% | - |
| Fidelity Small Cap Index | 2.13M | 1.01% | -40.14K |
| iShares Russell 2000 Value ETF | 1.78M | 0.84% | - |
| Fidelity Extended Market Index | 1.12M | 0.53% | 23.02K |
| Vanguard Russell 2000 ETF | 954.32K | 0.45% | 116.09K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 850.51K | 0.40% | -42.80K |
| Federated Hermes MDT Small Cap Growth IS | 809.71K | 0.39% | - |
| Federated Hermes MDT SCG Institutional | 809.71K | 0.39% | -1.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 13, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | $15.14K |
| May 13, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | $43.90K |
| Aug 25, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | $31.05K |
| Feb 29, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | $13.68K |
| Feb 29, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | $9.44K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | - | 2 |
| 2024 Q1 | - | 10 |
| 2023 Q3 | - | 1 |
| 2023 Q2 | - | 4 |
| 2023 Q1 | - | 19 |
AKBA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools